Drug application
ESCITALOPRAM OXALATE (ESCITALOPRAM OXALATE)
Drugs@FDA ANDA 202221 · HETERO LABS LTD III
Key facts
| Drug name | ESCITALOPRAM OXALATE |
|---|---|
| Active ingredients | ESCITALOPRAM OXALATE |
| Application type | ANDA |
| Application number | 202221 |
| Company | HETERO LABS LTD III |
| Dosage forms | SOLUTION, ORAL |
| Strength | EQ 5MG BASE/5ML |
| Marketing status | Prescription |
| TE codes | AA |
| Reference listed drug | No |
| Latest submission status date | Jun 12, 2012 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.